Position in AVIR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,106,722
-$295,935 QoQ
Shares Held
1,958,435
+12.1% QoQ
Ownership
2.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 124 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. AVIR ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,106,722 | 1,958,435 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,402,657 | 1,747,706 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,572,372 | 1,841,001 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,509,236 | 1,899,737 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,932,062 | 1,925,573 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,912,237 | 1,977,337 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,421,232 | 1,916,786 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,447,988 | 1,924,773 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,652,446 | 2,009,803 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $7,605,219 | 1,882,480 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,514,131 | 1,807,912 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,177,187 | 1,725,729 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,152,442 | 1,645,038 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,991,714 | 1,490,064 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,913,696 | 1,437,359 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,904,565 | 1,389,203 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,246,110 | 1,161,424 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,427,647 | 1,028,760 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,662,289 | 1,080,793 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $36,202,815 | 1,032,596 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,543,098 | 677,053 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,974,148 | 274,885 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $11,191,441 | 267,866 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||